Be unvaccinated and go out and party without a mask most likely for your bachelorette party brehettes
Coronavirus Thread: Worldwide Pandemic
- Thread starter 88m3
- Start date
Be unvaccinated and go out and party without a mask most likely for your bachelorette party brehettes
Poetical Poltergeist
Precise and cold hearted
Once you start talking politics its over. I have a co worker who I used to rap to all the time. Coo af dude but then Trump came along and this dude became a part of the cult. I can't fukk with him anymore. And he knows it.
choc_cardigan
Squad
That should be a whole separate thread. For his comedy and image, his friend list is, at the very least interesting.
mastermind
Rest In Power Kobe
They should too, and the US should waive the Moderna patent.
mastermind
Rest In Power Kobe
For "I believe in the science... except for profits" crowd
FDA staff say Pfizer COVID-19 boosters may not be needed, but do improve immunity
Sept 15 (Reuters) - U.S. Food and Drug Administration scientists said on Wednesday that booster doses of Pfizer's (PFE.N) COVID-19 vaccine may not be needed, even though the third shot generates a higher immune response in recipients.
The FDA staff members said in a document prepared for outside advisors that it is still unproven that the efficacy of Comirnaty - the COVID-19 vaccine Pfizer developed with Germany's BioNTech SE - is declining.
"Some observational studies have suggested declining efficacy of Comirnaty over time against symptomatic infection or against the Delta variant, while others have not," they said in the document.
"However, overall, data indicate that currently U.S.-licensed or authorized COVID-19 vaccines still afford protection against severe COVID-19 disease and death in the United States."
The FDA staff did say the booster dose met pre-specified conditions the regulator had set to show that the shot was generating an immune response.
However, they said in the document that licensure for the boosters should also consider ability to prevent hospitalization and death, as well as the dynamics of the pandemic in the United States.
The agency released the document on Wednesday for consideration by a committee of outside experts who will meet on Friday to decided whether to recommend if U.S regulators should approve the extra round of shots.
The FDA staff view reflects that of many scientists who have questioned whether the boosters are necessary broadly, even as President Joe Biden has pushed for the additional shots in the face of surging hospitalizations and deaths caused by the highly contagious Delta variant of the coronavirus.
After the FDA meets, a panel of advisors to the U.S. Centers for Disease Control and Prevention is planning to meet next week to make its recommendation, according to White House Press Secretary Jen Psaki.
PFIZER ARGUES BOOSTER APPROVAL
Pfizer, in a document it prepared for the meeting, argued that U.S. regulators should approve a booster shot of its vaccine for use six months after the second dose due to waning effectiveness over time.
Pfizer said data from its own clinical trials showed that the vaccine's efficacy diminished by around 6% every two months after the second dose. It also said the incidence of breakthrough COVID-19 cases in that trial was higher among people who received their shots earlier.
The company also pointed to real world data from Israel and the United States showing declining effectiveness of the Pfizer/BioNTech vaccine.
The U.S drugmaker said in a roughly 300-participant clinical trial, the third dose generated a better immune response than the second. It also pointed to data from the booster program recently started in Israel to show that a third dose restores high levels of protection from the virus.
Earlier this week, two top FDA vaccine scientists were among the authors of an article saying they do not believe the current data supports giving the shots. One of those scientists - Marion Gruber, director of the FDA's Office of Vaccines Research and Review - will be speaking at Friday's meeting.
Some U.S. officials are hoping boosters might prevent mild cases and reduce transmission of the virus as well as reducing COVID-19 hospitalizations and deaths, which could hasten America's recovery.
Some countries have already begun COVID-19 booster campaigns. The United States authorized extra shots for people with vulnerable immune systems last month.
Reporting by Michael Erman, Additional reporting from Manojna Maddipatla in Bengaluru; Editing by Nick Zieminski, Chizu Nomiyama and Bill Berkrot
FDA staff say Pfizer COVID-19 boosters may not be needed, but do improve immunity
Sept 15 (Reuters) - U.S. Food and Drug Administration scientists said on Wednesday that booster doses of Pfizer's (PFE.N) COVID-19 vaccine may not be needed, even though the third shot generates a higher immune response in recipients.
The FDA staff members said in a document prepared for outside advisors that it is still unproven that the efficacy of Comirnaty - the COVID-19 vaccine Pfizer developed with Germany's BioNTech SE - is declining.
"Some observational studies have suggested declining efficacy of Comirnaty over time against symptomatic infection or against the Delta variant, while others have not," they said in the document.
"However, overall, data indicate that currently U.S.-licensed or authorized COVID-19 vaccines still afford protection against severe COVID-19 disease and death in the United States."
The FDA staff did say the booster dose met pre-specified conditions the regulator had set to show that the shot was generating an immune response.
However, they said in the document that licensure for the boosters should also consider ability to prevent hospitalization and death, as well as the dynamics of the pandemic in the United States.
The agency released the document on Wednesday for consideration by a committee of outside experts who will meet on Friday to decided whether to recommend if U.S regulators should approve the extra round of shots.
The FDA staff view reflects that of many scientists who have questioned whether the boosters are necessary broadly, even as President Joe Biden has pushed for the additional shots in the face of surging hospitalizations and deaths caused by the highly contagious Delta variant of the coronavirus.
After the FDA meets, a panel of advisors to the U.S. Centers for Disease Control and Prevention is planning to meet next week to make its recommendation, according to White House Press Secretary Jen Psaki.
PFIZER ARGUES BOOSTER APPROVAL
Pfizer, in a document it prepared for the meeting, argued that U.S. regulators should approve a booster shot of its vaccine for use six months after the second dose due to waning effectiveness over time.
Pfizer said data from its own clinical trials showed that the vaccine's efficacy diminished by around 6% every two months after the second dose. It also said the incidence of breakthrough COVID-19 cases in that trial was higher among people who received their shots earlier.
The company also pointed to real world data from Israel and the United States showing declining effectiveness of the Pfizer/BioNTech vaccine.
The U.S drugmaker said in a roughly 300-participant clinical trial, the third dose generated a better immune response than the second. It also pointed to data from the booster program recently started in Israel to show that a third dose restores high levels of protection from the virus.
Earlier this week, two top FDA vaccine scientists were among the authors of an article saying they do not believe the current data supports giving the shots. One of those scientists - Marion Gruber, director of the FDA's Office of Vaccines Research and Review - will be speaking at Friday's meeting.
Some U.S. officials are hoping boosters might prevent mild cases and reduce transmission of the virus as well as reducing COVID-19 hospitalizations and deaths, which could hasten America's recovery.
Some countries have already begun COVID-19 booster campaigns. The United States authorized extra shots for people with vulnerable immune systems last month.
Reporting by Michael Erman, Additional reporting from Manojna Maddipatla in Bengaluru; Editing by Nick Zieminski, Chizu Nomiyama and Bill Berkrot
mastermind
Rest In Power Kobe
Its not that surprising, especially if you consider his content.
What do you mean ?
I watched some of his shows and never noticed any kind of antivax or far right stance.
ADevilYouKhow
Rhyme Reason
ADevilYouKhow
Rhyme Reason
mastermind
Rest In Power Kobe
Dave Chappelle's comedy isn't pro-black and super progressive. He talks a lot of shyt. This isn't 70s Richard Pryor at all.
I love dude for it, but it don't surprise me. Remember, he went out in the height of the pandemic last year to do a tour.
ADevilYouKhow
Rhyme Reason
ADevilYouKhow
Rhyme Reason
That’s awesome
Kyle C. Barker
Migos VERZUZ Mahalia Jackson
His material nowadays is definitely adjacent to the people he hangs out with. I do see how someone could get confused if they followed him in the 90s/2000s and watched his show but he's no longer the same person he was back then.